Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.
about
Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Erratum: A miRNA-based signatu ...... t trastuzumab-based treatment.
@en
type
label
Erratum: A miRNA-based signatu ...... t trastuzumab-based treatment.
@en
prefLabel
Erratum: A miRNA-based signatu ...... t trastuzumab-based treatment.
@en
P2093
P356
P1433
P1476
Erratum: A miRNA-based signatu ...... t trastuzumab-based treatment.
@en
P2093
P2888
P356
10.1038/SREP35509
P407
P577
2016-10-14T00:00:00Z
P6179
1018403476